Anti-inflammatory activity of constituents from Glechoma hederacea var. longituba

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 11, 2011, Pages 3483-3487

  Kim, Jinpyo ^a,c   Song, Seokbean ^a   Lee, Iksoo ^b   Kim, Youngho ^a   Yoo, Ickdong ^c   Ryoo, Inja ^c   Bae, Kihwan ^a  

^a Chungnam National University   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

COX 2; Glechoma hederacea; Inflammation; iNOS; Nf B; Rosmarinic acid

Indexed keywords

3' O METHYLROSMARINIC ACID; ANTIINFLAMMATORY AGENT; BENZYL 4' HYDROXYBENZOYL 3' O BETA DEXTROGLUCOPYRANOSIDE; CYCLOOXYGENASE 2 INHIBITOR; ETHYLROSMARINIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; METHYLISOFERULOYL 7 (3,4 DIHYDROXYPHENYL)LACTATE; METHYLROSMARINIC ACID; PLANT EXTRACT; PYRROLIDINE DITHIOCARBAMATE; ROSMARINIC ACID; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; ENZYME ANALYSIS; ENZYME INDUCTION; GLECHOMA HEDERACEA; MEDICINAL PLANT;

ANTI-INFLAMMATORY AGENTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEP G2 CELLS; HUMANS; LAMIACEAE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; NF-KAPPA B; PLANT EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

GLECHOMA HEDERACEA;

EID: 79956123316     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.02.002     Document Type: Article

References (20)

1. S.M. Lucas, N.J. Rothwell, and R.M. Gibson Br. J. Pharmacol. 147 2006 S232
2. L. Ferrero-Miliani, O.H. Nielsen, P.S. Andersen, and G. SE Clin. Exp. Immunol. 147 2007 227
3. K.H. Han, and K.T. Yoon Intervirology 51 2008 11
4. A.M. Elsharkawy, and D.A. Mann Hepatology 46 2007 590
5. H.J. An, H.J. Jeong, J.Y. Um, H.M. Kim, and S.H. Hong J. Ethnopharmacol. 106 2006 418
6. D. Jo, J. Lee, J. Noh, O. Kim, and J. Kwon J. Food Sci. Nutr. 6 2001 142
7. H. Yamauchi, R. Kakuda, Y. Yaoita, K. Machida, and M. Kikuchi Chem. Pharm. Bull. 55 2007 346
8. S.H. Park, H.S. Oh, M.A. Kang, H.J. Cho, J.B. Prasad, J.H. Won, and K.H. Lee Bioorg. Med. Chem. 15 2007 3938
9. I. Kiran, and N. Sarfraz Chem. Biodivers. 2 2005 104
10. H. Huang, H.D. Sun, M.S. Wang, and S.X. Zhao J. Nat. Prod. 59 1996 1079
11. S. Baba, N. Osakabe, M. Natsume, and J. Terao Life Sci. 75 2004 165
12. E.R. Woo, and M. Piao Arch. Pharm. Res. 27 2004 173
13. Z.J. Wang, Y.Y. Zhao, B. Wang, T.M. Ai, and Y.Y. Chen Chin. Chem. Lett. 11 2000 997
14. 3OD) in Table 1.
15. L.P. Liao, Z.M. Bi, P. Li, and T.D. Zhang Linchan Huaxue Yu Gongye 25 2005 13
16. 5 cells/mL (1.5 mL) in 6-well and grown for 24 h. All cells were transfected by the lipofectamine LTX (Invitrogen, Carlsbad, CA) as described by the manufacturer. Luciferase activity was assayed using an LB 953 Autolumat (EG&G Berthold, Nashua, NH) and was normalized based on the expression of RSV-β-galactosidase. β-Galactosidase activity was assayed colorimetrically. NF-κB-Luc plasmid was provided by Dr. Kyoon E. Kim (Department of Biochemistry, Chungnam National University).
17. 490 nm of the dissolved formazan product after addition of MTS for 30 min as described by the manufacturer (Promega, Madison, WI).
18. Total RNA extraction was isolated with Easy-blue reagent (Intron biotechnology, Seoul, Korea). Approximately 2 μg of total RNA were reverse transcribed using moloney murine leukemia virus (MMLV) reverse transcriptase and oligo-dT primers (Promega, Madison, WI) for 1 h at 42 °C. PCR for synthetic cDNA was performed using Taq polymerase pre-mixture (TaKaRa, Japan). PCR products were subjected to electrophoresis on 1% agarose gels and stained with EtBr. PCR was conducted with the following primer pairs: iNOS sense 5′-TCATCCGCTATGCTGGCTAC-3′, iNOS antisense 5′- CTCAGGGTCACGGCCATTG-3′, COX-2 sense 5′-GCCCAGCACTTCACGCATCAG- 3′, COX-2 antisense 5′-GACCAGGCACCAGACCAAAGACC-3′, GAPDH sense 5′-TGTTGCCATCAATGACCCCTT-3′, and GAPDH antisense 5′-CTCCACGACGTACTCAGCG-3′. The specificity of products generated by each set of primers was examined using gel electrophoresis.
19. J.S. Lee, E.S. Jung, Y.J. Kim, J.Y. Lee, J.H. Park, S.T. Hong, C.G. Hyun, D.H. Park, and Y.S. Kim Br. J. Pharmacol. 148 2006 366
20. S. Sakai, H. Kawamata, T. Kogure, N. Mantani, K. Terasawa, M. Umatake, and H. Ochiai Mediat. Inflammun. 8 1999 173